Search

everythinglearnresearchcommunity

for

Search:↓

Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Nuclear AR levels give better insight into hormone effects in skin conditions.

Adjusting minoxidil dosage may be safer than using bicalutamide for hair loss in women.

Female pattern hair loss, common in women, can be treated with oral antiandrogens and topical minoxidil, but these are more effective at preventing further loss than regrowing hair. Other helpful methods include counseling, cosmetic camouflage, and hair transplantation. Treatment must continue for effects to last and it may take up to 2 years to see results.

Spironolactone successfully treated hair loss in a 9-year-old girl.

Understanding hormones is key to treating certain skin conditions.

Understanding alopecia is crucial to improving care and addressing hair loss concerns.

Women with myotonic dystrophy might get diseases related to male hormones because their body tissues are extra sensitive to these hormones.

APKH in young males may signal early hair loss and needs early attention.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

The mouse model could be useful for baldness research and testing treatments like testosterone, cyproterone acetate, and minoxidil.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Androgens promote beard growth but cause hair loss in androgenetic alopecia, with TGF-β1 as a potential treatment target.

Spironolactone improved hair density and quality in women with hair loss.

The meeting presented new findings on hair stem cells, pigmentation, genetics, and modern hair treatment techniques.

Adiponectin reduces inflammation and bone loss in joint replacements.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.

Pattern hair loss is mainly caused by genetics and hormones, with limited effective treatments available.

Female hair loss can occur without androgens.

The unit area trichogram is a reliable method to assess hair loss and treatment response in people with androgenic alopecia by measuring hair density and thickness.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

The secretome from mesenchymal stromal cells shows promise for improving facial nerve injury treatment.

Common baldness treatments include cosmetic methods, medication like minoxidil, and surgery, but no cure exists.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Spironolactone effectively treats hormonal acne, hair loss, and excess hair growth in women.

A mushroom extract might reduce hair loss and liver damage caused by certain chemotherapy drugs in animals.